359
Participants
Start Date
May 23, 2022
Primary Completion Date
June 17, 2024
Study Completion Date
July 17, 2024
Unesbulin
Unesbulin will be administered as per the dose and schedule specified in the arm description.
Dacarbazine
Dacarbazine will be administered as per the dose and schedule specified in the arm description.
Placebo
Placebo will be administered as per the schedule specified in the arm description.
Prince of Wales Hospital, Randwick
Chris O'Brien Lifehouse, Camperdown
Peter MacCallum Cancer Institute, East Melbourne
The Trustees of Columbia University, New York
La Fondazione e l'Istituto di Candiolo, Torino
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
University of Pittsburgh Medical Center, Pittsburgh
University of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Johns Hopkins Oncology Group, Baltimore
Duke University Medical Center, Durham
Hospital Fundacion Jimenez Diaz, Madrid
Mayo Clinic, Jacksonville
University of Florida (UF) Health Cancer Center - Orlando Health, Orlando
Institut Bergonie, Bordeaux
Moffitt, Tampa
The Ohio State University (OSU), Columbus
University of Michigan, Ann Arbor
Northwestern Medicine - Warrenville Cancer Center, Warrenville
Northwestern Memorial Hospital, Chicago
Washington University, St Louis
Universitaetsmedizin Mannheim, Mannheim
Centre Leon Berard, Lyon
Institut Curie, Paris
MD Anderson Cancer Center, Houston
University of Colorado Denver, Denver
Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München
University of California, Los Angeles (UCLA) - Jonsson Comprehensive Cancer Center, Los Angeles
Sarcoma Oncology Research Center, Santa Monica
City of Hope, Duarte
Stanford Cancer Center, Stanford
Oregon Health & Science University, Portland
Yale University, New Haven
Fundacao PIO XII - Hospital de Amor, Barretos
Santa Casa de Misericordia de Porto Alegre, Porto Alegre
Hospital Sao Rafael - Instituto D'Or da Bahia, Salvador
CIP - Centro Integrado de Pesquisas do Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto
Instituto do Cancer do Estado de São Paulo (ICESP), São Paulo
Princess Margaret Hospital, Toronto
Universite de Montreal - Hopital Maisonneuve-Rosemont (HMR), Montreal
Gustave Roussy, Villejuif
Eszak-Pesti Centrumkorhaz - Honvedkorhaz, Budapest
Leids Universitair Medisch Centrum, Leiden
"Niepubliczny Zaklad Opieki Zdrowotnej Zespól Poradni Specjalistycznych TERMEDICA", Poznan
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Universitario 12 de Octubre, Madrid
The Christie NHS Foundation Trust, Manchester
INCA I - Instituto Nacional de Cancer, Rio de Janeiro
The Ottawa Hospital Cancer Centre, Ottawa
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, Warsaw
Institut Catala d'Oncologia (Hospital Duran y Reynals), Barcelona
Beatson, West of Scotland Cancer Centre, Glasgow
Royal Marsden Hospital, London
Lead Sponsor
PTC Therapeutics
INDUSTRY